Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;34(10):e574-e576.
doi: 10.1111/jdv.16734. Epub 2020 Jul 6.

The broad spectrum of dermatological manifestations in COVID-19: clinical and histopathological features learned from a series of 34 cases

C A Rubio-Muniz  1 , M Puerta-Peña  1 , D Falkenhain-López  1 , J Arroyo-Andrés  1 , M Agud-Dios  1 , J L Rodriguez-Peralto  2 , P L Ortiz-Romero  1 , R Rivera-Díaz  1
Affiliations

The broad spectrum of dermatological manifestations in COVID-19: clinical and histopathological features learned from a series of 34 cases

C A Rubio-Muniz et al. J Eur Acad Dermatol Venereol. 2020 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Rubio‐Muniz, Dr. Puerta‐Peña, Dr. Falkenhain‐López, Dr. Arroyo‐Andrés, Dr. Agud‐Dios, Dr. Rodriguez‐Peralto, Dr. Ortiz‐Romero and Dr. Rivera‐Díaz have nothing to disclose.

Figures

Figure 1
Figure 1
(a) Pseudo‐chilblains lesions on toes of a 17‐year‐old patient. (b) Erythemato‐purpuric macules with undefined limits on the heel of a COVID‐19 suspected patient. (c) Palpable purpura lesions on the lower extremities of a patient with COVID‐19 pneumonia. (d) Polymorphic papulovesicular eruption on a patient presenting simultaneously with palpable purpura on the lower extremities. (e). Targetoid lesions at a delayed phase of COVID‐19 pneumonia. (f) Maculopapular exanthem on a patient recovered from pneumonia; RT‐PCR test persisted positive.
See this image and copyright information in PMC

References

    1. Galván Casas C, Català A, Carretero Hernández G et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020. [Epub ahead of print]. 10.1111/bjd.19163 - DOI - PMC - PubMed
    1. Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol 2020; 34: e212–e213. - PubMed
    1. Recalcati S, Barbagallo T, Frasin LA et al. Acral cutaneous lesions in the time of COVID‐19. J Eur Acad Dermatol Venereol 2020. [Epub ahead of print]. 10.1111/jdv.16533 - DOI - PMC - PubMed
    1. Kolivras A, Dehavay F, Delplace D et al. Coronavirus (COVID‐19) infection‐induced chilblains: a case report with histopathological findings. JAAD Case Rep 2020; 6: 489–492. - PMC - PubMed
    1. Chen T, Dai Z, Mo P et al. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID‐19) in Wuhan, China (2019): a single‐centered, retrospective study. J Gerontol A Biol Sci Med Sci 2020. [Epub ahead of print]. 10.1093/gerona/glaa089 - DOI - PMC - PubMed

MeSH terms